Benzinga - Mon, 03 May 2021 13:30:55 -0400
Benzinga - Fri, 23 Apr 2021 10:12:20 -0400
Benzinga - Fri, 23 Apr 2021 07:28:51 -0400
Benzinga - Fri, 23 Apr 2021 07:25:18 -0400
Benzinga - Mon, 12 Apr 2021 05:10:38 -0400
Benzinga - Fri, 09 Apr 2021 12:44:35 -0400
Benzinga - Fri, 09 Apr 2021 12:02:10 -0400
Benzinga - Fri, 09 Apr 2021 09:37:07 -0400
Benzinga - Tue, 02 Mar 2021 13:46:55 -0400
Benzinga - Tue, 02 Mar 2021 12:17:51 -0400
Benzinga - Thu, 25 Feb 2021 08:59:27 -0400
Benzinga - Wed, 24 Feb 2021 17:49:17 -0400
Benzinga - Wed, 24 Feb 2021 17:08:04 -0400
Benzinga - Wed, 24 Feb 2021 17:07:03 -0400
Benzinga - Wed, 24 Feb 2021 08:30:10 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. NUZYRA (Omadacycline) is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. SEYSARA (Sarecycline) is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV
Q4 2020Est.ActualSurprise
EPS-0.040-0.490 -0.4500
REV34.040M16.019M-18.021M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PRTKParatek Pharmaceuticals1.1%344.4M

Paratek Pharmaceuticals Company Questions & Answers

Q

How do I buy Paratek Pharmaceuticals (PRTK) stock?

A

You can purchase shares of Paratek Pharmaceuticals (NASDAQ: PRTK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Paratek Pharmaceuticals's (PRTK) main competitors?

A

Other companies in Paratek Pharmaceuticals’s space includes: BioDelivery Sciences Intl (NASDAQ:BDSI), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).

Q

What is the target price for Paratek Pharmaceuticals?

A

The latest price target for Paratek Pharmaceuticals (NASDAQ: PRTK) was reported by WBB Securities on 2021-04-23. The analyst firm set a price target for 10.00 expecting PRTK to rise to within 12 months (a possible 36.24% upside). 5 analyst firms have reported ratings in the last year.

Q

How much is Paratek Pharmaceuticals (PRTK) stock ?

A

The stock price for Paratek Pharmaceuticals (NASDAQ: PRTK) is $7.34 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Paratek Pharmaceuticals (PRTK) dividend?

A

There are no upcoming dividends for Paratek Pharmaceuticals.

Q

When is Paratek Pharmaceuticals (NASDAQ:PRTK) reporting earnings?

A
Paratek Pharmaceuticals’s Q2 earnings are confirmed after-market from now on August 9, 2021.
Q

When is the upcoming split for PRTK?

A

There is no upcoming split for Paratek Pharmaceuticals.